Viewing Study NCT04278235


Ignite Creation Date: 2025-12-24 @ 10:35 PM
Ignite Modification Date: 2026-01-01 @ 6:34 AM
Study NCT ID: NCT04278235
Status: AVAILABLE
Last Update Posted: 2025-07-10
First Post: 2020-02-18
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access to Elezanumab
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module